Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2026-04-23 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于召开2025年年度股东会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2025 Annual General Meeting (AGM) of shareholders for the company 重药控股股份有限公司. It includes details about the meeting date, voting procedures, agenda items including the annual report, financial statements, profit distribution plan, and other shareholder meeting logistics. The document does not contain the actual annual report or financial statements but rather announces the meeting where these will be discussed and voted upon. The document length is 4065 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2026-04-23 Chinese
2025年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2025 Annual Report Summary" of Chongqing Pharmaceutical Holdings Co., Ltd. It contains detailed financial data for the year 2025, including total assets, net profit, earnings per share, and quarterly financial data. It also includes information about shareholders, stock codes, bond information, and business segments. The length of the document is substantial (15,000 characters), and it contains comprehensive financial and operational data typical of an annual report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2025
2026-04-23 Chinese
2026年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2026 年第一季度报告' which translates to '2026 First Quarter Report'. It contains detailed financial data including income, net profit, cash flow, assets, liabilities, shareholder information, and a consolidated balance sheet as of March 31, 2026. The presence of comprehensive financial statements and analysis for a quarter indicates this is a quarterly financial report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-23 Chinese
2025年度会计师事务所履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm (致同会计师事务所) for the fiscal year 2025. It details the qualifications, independence, quality management, and audit service level of the auditor for the company's 2025 financial report and internal control audit. It is not the audit report itself but an assessment of the auditor's performance and compliance with regulations. The document length is 2199 characters, which is relatively short and focused on evaluation rather than presenting financial statements or audit results. Therefore, it fits the category of an Audit Report / Information (AR), which includes standalone audit reports and related information about audit quality and procedures, excluding full annual reports. FY 2025
2026-04-23 Chinese
关于重药控股股份有限公司涉及财务公司关联交易的存款、贷款等金融业务的专项说明
Audit Report / Information Classification · 95% confidence The document is a special explanation regarding related party financial transactions involving deposits and loans between Zhongyao Holdings Co., Ltd. and financial companies. It includes a summary table of these transactions for the year 2025 and references an audit report with an unqualified opinion issued by Grant Thornton. The document is addressed to the company's shareholders and is intended for disclosure in the annual report. It is not the annual report itself but a supplementary audit-related explanation focusing on related party transactions and financial dealings. The document length is 2384 characters, which is relatively short and focused on audit-related financial information about related party transactions. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related explanation and not the full annual report or a regulatory announcement. Therefore, the appropriate classification is AR with high confidence. FY 2025
2026-04-23 Chinese
上市公司非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 90% confidence The document contains detailed tabular financial data related to non-operating fund occupation and related party transactions for the year 2025, including amounts at the beginning and end of the period, cumulative amounts, and interest details. The presence of substantive financial data and accounting details indicates this is a financial report rather than a brief announcement or certification. The content is consistent with a comprehensive financial report for a period shorter than a full fiscal year, likely an interim or quarterly report. There is no indication that this is an annual report, audit report, or other specific filing types such as earnings release or management report. Therefore, the document is best classified as an Interim / Quarterly Report (IR). FY 2025
2026-04-23 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.